Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLK1 | P53350 | 8/20 | 0.36 |
| ▸ | GPR55 | Q9Y2T6 | 2/20 | 0.34 |
| ▸ | HTT | P42858 | 2/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | PLK3 | Q9H4B4 | 6/20 | 0.33 |
| ▸ | PDGFRB | P09619 | 5/20 | 0.33 |
| ▸ | KDR | P35968 | 5/20 | 0.33 |
| ▸ | RPS6KA2 | Q15349 | 2/20 | 0.33 |
| ▸ | KIT | P10721 | 2/20 | 0.33 |
| ▸ | FGFR1 | P11362 | 2/20 | 0.33 |
| ▸ | FLT3 | P36888 | 2/20 | 0.33 |
| ▸ | TERT | O14746 | 1/20 | 0.33 |
| ▸ | LCK | P06239 | 1/20 | 0.33 |
| ▸ | F11 | P03951 | 1/20 | 0.33 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.33 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3932538 | 1.00 | PLK1 (0.36) | PLK1GPR55HTTNPC1RAB9A | |
| SCHEMBL5858305 | 0.96 | GPR55 (0.35) | PLK1GPR55HTTNPC1RAB9A | |
| SCHEMBL3931789 | 0.96 | GPR55 (0.35) | PLK1GPR55HTTNPC1RAB9A | |
| SCHEMBL3944370 | 0.95 | HTT (0.38) | PLK1HTTNPC1RAB9APLK3 | |
| SCHEMBL5859511 | 0.95 | HTT (0.38) | PLK1HTTNPC1RAB9APLK3 | |
| SCHEMBL3935373 | 0.91 | PLK1 (0.35) | PLK1HTTNPC1RAB9AKMT2A | |
| SCHEMBL5857433 | 0.91 | PLK1 (0.35) | PLK1HTTNPC1RAB9AKMT2A | |
| SCHEMBL3934811 | 0.91 | NPC1 (0.39) | PLK1HTTNPC1RAB9AMEN1 | |
| SCHEMBL5858293 | 0.91 | NPC1 (0.39) | PLK1HTTNPC1RAB9AMEN1 | |
| SCHEMBL225449 | 0.87 | LRRK2 (0.36) | PLK1NPC1RAB9APLK3PDGFRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7148249-B2 | Indolinones substituted by heterocycles, the preparation thereof and their use as medicaments | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2006-12-12 | — | — | US | disclosed |
| US-20050054710-A1 | Indolinones substituted by heterocycles, the preparation thereof and their use as medicaments | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2005-03-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050054710-A1 | Indolinones substituted by heterocycles, the preparation thereof and their use as medicaments | CDK1, CDK2, CDK3 | PLK1 86/4885GPR55 970/4885HTT 4263/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.